Forbes December 6, 2022
Joshua Cohen

At Illumina’s Genomics Forum conference this fall, former President Obama spoke about how precision medicine has a “considerable role to play in making the health system more efficient and producing better outcomes,” but that it has not yet realized its full potential.

Indeed, precision medicine holds tremendous promise, but still has a long way to go, in particular with respect to efficiently connecting the dots between diagnostics and therapeutics during clinical development.

Clinical validity and utility

Precision medicine relies on the clinical validity of diagnostic tests, or the accurate identification of patients with certain biomarker alterations. Clinical validity is, however, a necessary and not a sufficient condition for successful implementation of personalized medicine. To achieve success, clinical utility is needed,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article